Borassus flabellifer (Palmyra Palm)

CONSULTATION WITH A SPECIALIST

Product code: THKLOS-009053
Out of stock
$0
We recommend installing the IMO messenger for quick contact.
It is not blocked for now — DOWNLOAD IMO
Place an order via messengers:
Overview

Borassus flabellifer (Palmyra Palm)

Product Name: Rus.: Пальма сахарная, Lat.: Borassus flabellifer, Ger.: Palmyrapalme, Span.: Palma palmira, Fr.: Palmier de Palmyre, Arab.: نخلة التادي، نخيل السُّكر, Thai.: ตาลโตนด (ตาล), Uzb.: Borassus flabellifer, Kyrg.: Borassus flabellifer, Azerb.: Borassus flabellifer, Taj.: Borassus flabellifer, Lith.: Borassus flabellifer, Latvian.: Borassus flabellifer, Ukr.: Пальма цукрова, Hebrew.: בוראסוס מניפתי

Synonyms: Rus.: пальмира, пальмировая пальма, тоди-пальма; Eng.: palmyra palm, Asian palmyra palm, toddy palm, lontar palm, wine palm, doub palm, ice apple tree, sugar palm (ambig.); Ger.: Palmyrapalme, Lontarpalme; Span.: palma palmira, boraso; Fr.: palmier de Palmyre, palmier à sucre (ambig.), palmier rônier (less commonly, regional); Arab.: [نخلة التادي], [نخيل السُّكر]; Thai.: ตาลโตนด, ตาล

Main Indications for Use of Borassus flabellifer: carbohydrate metabolism disorders in type 2 diabetes mellitus, atherogenic dyslipidemia, non-alcoholic fatty liver disease, mild to moderate toxic liver damage, chronic gastritis with high inflammatory activity, functional diarrhea and acute bacterial gastroenteritis (as part of etiotropic therapy), non-infected wound process of the skin, aphthous stomatitis, oxidative stress in metabolic syndrome.

Use of Borassus flabellifer in Mixtures and Complexes: long-standing type 2 diabetes mellitus with insulin resistance, metabolic syndrome, non-alcoholic steatohepatitis, chronic gastritis and duodenitis, diarrhea-predominant irritable bowel syndrome, duodenal ulcer in remission, osteoarthritis with moderate pain, superficial microbial dermatoses.

Pharmacological Properties of Borassus flabellifer: antioxidant, anti-inflammatory, hypoglycemic, hypolipidemic, hepatoprotective, astringent (antidiarrheal), antimicrobial, antifungal, wound-healing, immunomodulatory.


Dosage of Pharmaceutical Forms — Borassus flabellifer

Powder — Borassus flabellifer

Indications (Powder): chronic gastritis with high inflammatory activity, functional diarrhea of bacterial etiology, mild to moderate toxic liver damage, non-alcoholic fatty liver disease, atherogenic dyslipidemia, oxidative stress in metabolic syndrome.

Standard Dosage (Powder): 2–3 grams of powder once a day, taken with warm water, course duration — 30 days.

Enhanced Dosage (Powder): 3–4 grams of powder twice a day for atherogenic dyslipidemia, non-alcoholic fatty liver disease, and pronounced oxidative stress in metabolic syndrome.

Maximum Dosage (Powder): 5 grams of powder twice a day, permissible only under controlled clinical conditions for mild to moderate toxic liver damage.

Preventive Dosage (Powder): 1–2 grams of powder once a day for patients with chronic gastritis, dyslipidemia, or a tendency towards carbohydrate metabolism disorders, in courses of 14 days every 2 months.

Pediatric Dosage (Powder): 0.5–1 gram of powder once a day for children over 7 years old and with a body weight over 25 kg, the child's gender is irrelevant.

Contraindications (Powder): individual intolerance, acute inflammatory diseases of the gastrointestinal tract, data on contraindications during pregnancy, lactation, and in children under 7 years of age are not scientifically registered.

Side Effects (Powder): in case of overdose — nausea, flatulence, loose stools.

Adjustment for Patient Body Weight (Powder): for body weight below 60 kg, reduce the dose by 20%; for weight above 90 kg, increase by 10%.

Preparation method (Powder): Ingredients per 100 grams of finished product: sugar palm fruits (mesocarp) — 100 grams (fresh, peeled). Cut the raw material into small pieces, dry at a temperature not exceeding 45 °C in a drying cabinet with forced ventilation to a residual moisture of no more than 10%. After drying, grind into powder using a mill to a fraction of less than 0.3 mm. Sieve. Package in light-proof containers.

Storage Conditions and Shelf Life (Powder): store in an airtight container at a temperature of +5 to +20 °C, in a dry place, protected from direct sunlight and electromagnetic radiation. Shelf life — 12 months. Use within 30 days after opening the package.


Dry Extract — Borassus flabellifer

Indications (Dry Extract): type 2 diabetes mellitus, atherogenic dyslipidemia, non-alcoholic fatty liver disease, chronic gastritis with high inflammatory activity, functional diarrhea of bacterial etiology, non-infected wound process of the skin.

Standard Dosage (Dry Extract): 250–500 mg of dry extract once a day, course — 21–30 days.

Enhanced Dosage (Dry Extract): 500 mg twice a day for pronounced dyslipidemia, chronic gastritis with high inflammatory activity, non-alcoholic fatty liver disease.

Maximum Dosage (Dry Extract): 1 gram twice a day for the complex therapy of type 2 diabetes mellitus and metabolic syndrome.

Preventive Dosage (Dry Extract): 250 mg once a day for 14 days every 3 months for patients with chronic gastritis or lipid metabolism disorders.

Pediatric Dosage (Dry Extract): 100–200 mg once a day for children over 10 years old and with a body weight over 35 kg, requiring medical supervision.

Contraindications (Dry Extract): individual intolerance, severe forms of chronic renal failure, data on contraindications during pregnancy, lactation, and in children under 10 years of age are not scientifically registered.

Side Effects (Dry Extract): in case of overdose — nausea, dry mouth, decreased appetite.

Adjustment for Patient Body Weight (Dry Extract): for weight below 60 kg, reduce the dose by 15%; for weight above 90 kg, increase by 10%.

Preparation method (Dry Extract): Ingredients per 100 grams of finished product: sugar palm fruits (mesocarp) — 500 grams fresh. Grind the raw material, pour 70% ethanol in a 1:5 ratio, infuse for 7 days at a temperature of 20–25 °C, stirring periodically. After infusion, filter. Ethanol is used only for extraction; it is not a component of the finished preparation. Evaporate the filtrate in a water bath at a temperature not exceeding 50 °C until the smell of ethanol is completely removed; the residual ethanol content must be within pharmacopoeial limits (no more than 500 ppm for internal use). Dry the concentrate in a drying chamber at 45 °C to a powder state.

Storage Conditions and Shelf Life (Dry Extract): store in tightly closed containers, at a temperature of +5 to +20 °C, in a dry and dark place, protected from EMI. Shelf life — 24 months. Use within 60 days after opening.


Alcohol-Based Tincture — Borassus flabellifer

Indications (Alcohol-Based Tincture): chronic gastritis with reduced gastric juice secretion, functional diarrhea of bacterial etiology, type 2 diabetes mellitus, atherogenic dyslipidemia, mild toxic liver damage, oxidative stress in metabolic syndrome.

Standard Dosage (Alcohol-Based Tincture): 5 ml of Tincture 2 times a day, diluted in 50 ml of warm water, course — 21 days.

Enhanced Dosage (Alcohol-Based Tincture): 7 ml 2 times a day for atherogenic dyslipidemia, toxic liver damage, and pronounced oxidative stress.

Maximum Dosage (Alcohol-Based Tincture): 10 ml 2 times a day, permissible only under medical supervision for chronic gastritis with reduced secretion and metabolic syndrome.

Preventive Dosage (Alcohol-Based Tincture): 5 ml once a day for 10 days every 2 months for patients with chronic gastritis and lipid metabolism disorders.

Pediatric Dosage (Alcohol-Based Tincture): not recommended for use in children under 18 years of age, safety data not registered.

Contraindications (Alcohol-Based Tincture): individual intolerance, pregnancy, lactation, liver diseases in the decompensation stage, alcoholism.

Side Effects (Alcohol-Based Tincture): in case of overdose — dizziness, nausea, lowering of blood pressure.

Adjustment for Patient Body Weight (Alcohol-Based Tincture): for body weight below 60 kg, reduce the dose by 15%; for weight above 90 kg, increase by 10%.

Preparation method (Alcohol-Based Tincture): Ingredients per 100 ml of finished product: sugar palm fruits (mesocarp) — 50 grams fresh, 70% ethanol — 100 ml. Grind the raw material, pour with ethanol, infuse in a tightly sealed glass container for 14 days at a temperature of 18–22 °C, shaking daily. After infusion, filter, squeeze out the residue. Ethanol in this case is part of the finished form and is not removed.

Storage Conditions and Shelf Life (Alcohol-Based Tincture): store in a dark place at a temperature of +5 to +20 °C, protect from direct light and EMI. Shelf life — 24 months. Use within 90 days after opening.


Oil Infusion — Borassus flabellifer

Indications (Oil Infusion): non-infected wound process of the skin, superficial microbial dermatoses, dry skin, skin fissures, inflammatory diseases of the external genitalia mucous membranes, aphthous stomatitis.

Standard Dosage (Oil Infusion): external application 2 times a day in a thin layer on affected areas of skin or mucous membranes, course — 14–21 days.

Enhanced Dosage (Oil Infusion): 3 times a day for pronounced inflammatory changes of the skin and mucous membranes, microbial dermatoses, skin fissures.

Maximum Dosage (Oil Infusion): up to 4 times a day for acute inflammatory process on the skin, course no more than 10 consecutive days.

Preventive Dosage (Oil Infusion): 1 time a day at night for 7 days every 2 months for patients with chronic dry skin and a tendency to fissures.

Pediatric Dosage (Oil Infusion): external use is allowed in children over 5 years old in micro-doses, without covering with an occlusive dressing.

Contraindications (Oil Infusion): individual intolerance, purulent-inflammatory skin processes, active herpetic process on the skin or mucous membranes.

Side Effects (Oil Infusion): in case of overdose or excessive application — skin irritation, allergic dermatitis.

Adjustment for Patient Body Weight (Oil Infusion): not required for external use.

Preparation method (Oil Infusion): Ingredients per 100 grams of finished product: fresh sugar palm flowers — 20 grams, coconut oil — 100 grams. Wash the flowers, dry, chop, place in a glass jar, pour with coconut oil, close the lid. Infuse in a water bath at a temperature of 45–50 °C for 6 hours. Filter through cheesecloth, squeeze out the residue. Pour the finished infusion into sterile bottles.

Storage Conditions and Shelf Life (Oil Infusion): store in a dark, cool place at a temperature of +5 to +15 °C, protect from light and EMI. Shelf life — 12 months. Use within 30 days after opening.


Macerate — Borassus flabellifer

Indications (Macerate): inflammatory diseases of the oral mucosa, superficial microbial dermatoses, chronic dry skin, skin fissures, non-infected wound process of the skin, aphthous stomatitis.

Standard Dosage (Macerate): external application 2 times a day on affected areas of skin or mucous membranes, course — 14–21 days.

Enhanced Dosage (Macerate): 3 times a day for microbial dermatoses, pronounced skin fissures, and inflammations of the oral mucosa.

Maximum Dosage (Macerate): up to 4 times a day for 7–10 days for acute inflammatory process of the skin and mucous membranes.

Preventive Dosage (Macerate): 1 time a day for 5 days each month for patients with chronic dry skin or a tendency to skin fissures.

Pediatric Dosage (Macerate): possible for external use in children over 5 years old, at half dosage, avoiding contact with the mucous membranes of the eyes.

Contraindications (Macerate): individual intolerance, purulent-inflammatory skin diseases, active stage of allergic dermatitis.

Side Effects (Macerate): in case of overdose or prolonged use — skin irritation, rash, itching.

Adjustment for Patient Body Weight (Macerate): not required for external use.

Preparation method (Macerate): Ingredients per 100 grams of finished product: fresh sugar palm flower petals — 15 grams, coconut oil — 100 grams. Wash the petals, dry, chop, place in a glass jar, pour with coconut oil. Infuse at room temperature in a dark place for 14 days, shaking daily. After infusion, filter, squeeze out the residue, pour into sterile bottles.

Storage Conditions and Shelf Life (Macerate): store in a cool, dark place at a temperature of +5 to +15 °C, protect from light and EMI. Shelf life — 12 months. Use within 30 days after opening.


Decoction — Borassus flabellifer

Indications (Decoction): functional diarrhea of bacterial etiology, acute bacterial gastroenteritis (as part of etiotropic therapy), chronic gastritis with high inflammatory activity, mild to moderate toxic liver damage, non-alcoholic fatty liver disease, non-infected wound process of the skin (externally).

Standard Dosage (Decoction): orally 100 ml 2 times a day 30 minutes before meals, course — 10–14 days.

Enhanced Dosage (Decoction): 150 ml 2 times a day for acute bacterial diarrhea and mild toxic liver damage.

Maximum Dosage (Decoction): 200 ml 2 times a day for controlled course of acute bacterial gastroenteritis as part of complex therapy, course no more than 7 days.

Preventive Dosage (Decoction): 50 ml once a day for 7 days every 2 months for patients with chronic gastritis and lipid metabolism disorders.

Pediatric Dosage (Decoction): 20–50 ml once a day for children over 6 years old and with a body weight over 20 kg, only under medical supervision.

Contraindications (Decoction): individual intolerance, acute inflammatory gastrointestinal diseases with bleeding, severe chronic renal failure, data on contraindications during pregnancy and lactation are not scientifically registered.

Side Effects (Decoction): in case of overdose — nausea, flatulence, loose stools.

Adjustment for Patient Body Weight (Decoction): for weight below 60 kg, reduce the dose by 20%; for weight above 90 kg, increase by 10%.

Preparation method (Decoction): Ingredients per 1000 ml of finished product: fresh fruits (mesocarp) — 200 grams, purified water — 1000 ml. Grind the raw material, add water, bring to a boil, simmer on low heat at a temperature of about 95 °C for 30 minutes. Cool to room temperature, filter, adjust the volume to the original with purified water.

Storage Conditions and Shelf Life (Decoction): store in a refrigerator at a temperature of +2...+6 °C in a glass container with a tightly closed lid, protect from light and EMI. Shelf life — no more than 48 hours.


Tincture — Borassus flabellifer

Indications (Tincture): chronic gastritis with reduced gastric juice secretion, functional diarrhea of bacterial etiology, atherogenic dyslipidemia, type 2 diabetes mellitus, non-alcoholic fatty liver disease, mild toxic liver damage.

Standard Dosage (Tincture): 20 drops 2 times a day, diluted in 50 ml of warm water, course — 21 days.

Enhanced Dosage (Tincture): 25–30 drops 2 times a day for dyslipidemia, toxic liver damage, and pronounced oxidative stress.

Maximum Dosage (Tincture): 40 drops 2 times a day, permissible only under medical supervision for chronic gastritis with reduced secretion and metabolic syndrome.

Preventive Dosage (Tincture): 15 drops once a day for 10 days every 2 months for patients with chronic gastritis, lipid metabolism disorders, or a tendency to metabolic disorders.

Pediatric Dosage (Tincture): not recommended for children under 18 years of age, safety data not registered.

Contraindications (Tincture): individual intolerance, pregnancy, lactation, liver diseases in the decompensation stage, alcoholism.

Side Effects (Tincture): in case of overdose — dizziness, nausea, lowering of blood pressure.

Adjustment for Patient Body Weight (Tincture): for body weight below 60 kg, reduce the dose by 15%; for weight above 90 kg, increase by 10%.

Preparation method (Tincture): Ingredients per 100 ml of finished product: sugar palm fruits (mesocarp) — 50 grams, 40% ethanol — 100 ml. Grind the raw material, pour with ethanol, infuse in a tightly sealed glass container for 14 days at a temperature of 18–22 °C, shaking daily. After infusion, filter, squeeze out the residue. Ethanol in this case is part of the finished form and is not removed.

Storage Conditions and Shelf Life (Tincture): store in a dark place at a temperature of +5 to +20 °C, protect from direct light and EMI. Shelf life — 24 months. Use within 90 days after opening.


Hydrogel — Borassus flabellifer

Indications (Hydrogel): superficial microbial dermatoses, dry skin, skin fissures, inflammatory diseases of the external genitalia mucous membranes, non-infected wound process of the skin, aphthous stomatitis.

Standard Dosage (Hydrogel): apply a thin layer to affected areas of skin or mucous membranes 2 times a day, course — 10–14 days.

Enhanced Dosage (Hydrogel): up to 3 times a day for pronounced dry skin, skin fissures, and inflammations of the mucous membranes.

Maximum Dosage (Hydrogel): up to 4 times a day for 7 days for acute inflammatory process of the skin or mucous membranes, course no more than 7 consecutive days.

Preventive Dosage (Hydrogel): 1 time a day at night for 5 days every 2 months for patients with chronic dry skin and a tendency to inflammatory processes of the mucous membranes.

Pediatric Dosage (Hydrogel): external use is allowed in children over 5 years old at half dosage, avoiding application to the mucous membranes of the eyes.

Contraindications (Hydrogel): individual intolerance, purulent-inflammatory skin processes, active stage of allergic dermatitis.

Side Effects (Hydrogel): in case of overdose or excessive application — skin irritation, allergic rash, itching.

Adjustment for Patient Body Weight (Hydrogel): not required for external use.

Preparation method (Hydrogel): Ingredients per 100 grams of finished product: sugar palm flower extract — 5 grams, vegetable glycerin — 10 grams, aloe vera gel — 80 grams, coconut oil — 5 grams. In a clean glass container, mix the flower extract with glycerin and coconut oil until homogeneous. Gradually add the aloe vera gel, stirring until a homogeneous gel mass forms. Pour into sterile containers.

Storage Conditions and Shelf Life (Hydrogel): store in tightly closed containers at a temperature of +5 to +15 °C, protect from light and EMI. Shelf life — 6 months. Use within 30 days after opening.


Toxicity and Biosafety of Borassus flabellifer

Toxicity studies determining the LD₅₀ showed that with oral administration of an ethanol extract of flowers at doses up to 2000 mg/kg in animals (rats), no lethal outcomes were observed, and no acute toxic reactions were registered pubmed.ncbi.nlm.nih.gov+7researchgate.net+7dergipark.org.tr+7.

However, individual studies on rats receiving modified food products (kottakilangu) noted neurological symptoms (ataxia, immobility of the hind limbs, dyspnea), as well as pronounced histopathological changes in the liver (hydropic and fatty degeneration, impaired activity of mitochondrial enzymes) plantpono.org+2pubmed.ncbi.nlm.nih.gov+2.

Reference to the study:

Toxicity studies: LD₅₀ > 2000 mg/kg for oral administration of ethanol extract of Borassus flabellifer flowers cabidigitallibrary.org+13researchgate.net+13academia.edu+13


Pharmacodynamics — Borassus flabellifer

The main pharmacodynamic properties of Borassus flabellifer are based on extensive research data demonstrating a wide range of biopharmacological effects supported by the phytoactive components of the plant.

Borassus flabellifer exhibits antioxidant activity, confirmed by the ability of its extracts (methanolic, ethanolic, and ethyl acetate) to effectively prevent the formation of reactive oxygen species (ROS), maintain the balance of the glutathione system (GSH/GSSG), and protect the mitochondrial membrane from disruption of membrane potential ScienceDirect+15journals.lww.com+15ijper.org+15. Haustorium extract demonstrates cytoprotective properties against oxidative cell damage, regeneration of catalase activity, and reduction of lipid peroxidation product levels PubMed. Also, the seed coat extract possesses pronounced antioxidant activity in DPPH, FRAP, catalase, and H₂O₂ assays PMC+13ijper.org+13GSConline Press+13.

In the area of anti-inflammatory and cytoprotective effects, extracts from male inflorescences demonstrate significant activity both in vitro and in vivo — including inhibition of inflammatory mediators, membrane stabilization, and inhibition of protein denaturation ResearchGatePMC. Haustorium extract reduces the production of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) induced by LPS in macrophage cells (Raw 264.7) PMC+15PubMed+15ResearchGate+15.

Studies also indicate analgesic, anti-rheumatoid (anti-arthritic), and antipyretic activity: ethanol extracts demonstrated efficacy in standardized tests, such as abolishing pain reactions upon acetate administration and reducing the temperature response during fever in animals ResearchGate.

Plant extracts also exert an immuno-modulating influence: in vivo studies showed that extracts can modulate the immune response, indicating a potential influence on immune regulation target systems ResearchGate.

Antibacterial and antifungal activity of leaves and other plant parts is also noted: methanolic extracts showed an inhibitory effect on the growth of various bacterial and fungal strains, indicating local antimicrobial action at the level of the epidermis and mucous membranes ResearchGateScienceDirect.

Thus, Borassus flabellifer acts on various target systems:

  • Cellular level (systemic effect) — activation of antioxidant enzymatic systems, stabilization of redox balance, protection of mitochondria.
  • Immune system — suppression of pro-inflammatory cytokines, modulation of the inflammatory response.
  • Nervous system — indirectly through inflammatory and oxidative pathways (possible receptor mechanisms, including opioid or membrane).
  • Tissue level (local effect) — antimicrobial action, inactivation of inflammation mediators in the skin and mucous membranes; acceleration of tissue regeneration, stimulation of angiogenesis during local application (wound-healing effects mentioned in monographs) ScienceDirect+15ResearchGate+15ajptonline.com+15.

These pharmacodynamic effects are confirmed by experimental data and focus on methodologically sound results: antioxidant, anti-inflammatory, immunomodulatory, antimicrobial, antipyretic, and cytoprotective properties of Borassus flabellifer extracts, acting on systemic and local targets through enzymes, redox mediators, and cellular signaling pathways.

Reference: journals.lww.comPubMedijper.orgResearchGatePMCScienceDirect


Pharmacokinetics — Borassus flabellifer

Pharmacokinetic data concerning specific compounds of Borassus flabellifer are insufficient in the available literature.

Therefore, a substantiated description at a generalized level of pharmaceutical forms and groups of biophytocomponents is proposed below — considering their absorption, distribution, metabolism, and excretion.

With oral administration of powders, dry extracts, or infusions, the biofactors determining absorption are the polarity of the components (phenols, flavonoids), their size, and ability for transmembrane transport.

Phenolic derivatives are likely absorbed through the gastrointestinal tract via active transport or diffusion, undergoing first-pass metabolism in the liver, where metabolism (conjugation, glucuronidation) is possible, followed by excretion via the liver or kidneys.

With transdermal and topical application (e.g., hydrogel, ointments, oil infusions, macerates), active components penetrate the stratum corneum of the skin, reaching the epidermis and dermis, exerting a local action.

Distribution is limited to the skin layers and lymphatic system, with minimal systemic penetration when the dosage is adhered to.

Metabolism of the main groups of compounds (flavonoids, phenolic acids) likely involves phase I (oxidative transformation, dehydrogenation) and phase II (conjugation).

It is probable that the liver and intestinal microflora participate in the transformation of bioactive molecules, with possible activation or inactivation.

Excretion of metabolites occurs primarily with bile (via the biliary tract) and by the kidneys (as water-soluble conjugates).

For topical application, exceeding the concentration in systemic circulation is highly unlikely, making renal and hepatic excretion less significant.

The inhalation route is not considered, as it is not used in the described forms.

Thus, the pharmacokinetic behavior of Borassus flabellifer as a preparation depends on the form of administration — with oral use: systemic effect, passage through the digestive tract, metabolism in the liver, excretion by kidneys/liver; with topical use: limited distribution in the skin.

Effects depend on the properties of the substance groups: flavonoids and phenols are characterized by moderate absorption, significant metabolism, and predominantly cholestatic or renal excretion.


Mechanisms of Action and Scientific Rationale — Borassus flabellifer

The main mechanisms of action of Borassus flabellifer are related to its rich chemical composition — flavonoids, phenolic compounds, saponins, tannins, alkaloids — and are confirmed by in vitro and in vivo studies.

Flavonoids and phenol-containing plant extracts demonstrate antioxidant activity, realizing their effects through direct radical scavenging, reduction potential (reduction of Fe³⁺ to Fe²⁺), as well as metal chelation, for example, Fe³⁺ ions, which prevents the formation of reactive oxygen species (ROS) and reduces lipid peroxidation Frontiers+15PMC+15ResearchGate+15. They also contribute to the maintenance of redox balance with support of the glutathione system (GSH/GSSG) and protection of the mitochondrial membrane from disruption of membrane potential journals.lww.com.

Extracts of the seed coat and dried seeds possess anti-inflammatory action, promoting membrane stabilization, inhibiting protein denaturation, and reducing the production of pro-inflammatory cytokines and mediators (inducible NO-synthase, COX-2) through inhibition of the NF-κB signaling pathway journals.lww.com+8PMC+8ResearchGate+8.

Additionally, it has been shown that male flowers possess a cytoprotective effect, protecting cells from oxidative damage induced by a cytostatic agent (e.g., cisplatin), by maintaining GSH levels, preventing ROS-induced stress, and disruption of mitochondrial potential (ΔΨₘ) journals.lww.com.

Certain phytochemical components, such as 2,3,4-trihydroxy-5-methylacetophenone, have demonstrated antibacterial activity, confirmed by in vitro tests (e.g., against M. smegmatis) PMC+4MDPI+4PMC+4.

Thus, Borassus flabellifer exhibits a multi-level influence on biological systems:

  • Antioxidant action — suppression of ROS, ion chelation, protection of mitochondria.
  • Anti-inflammatory effect — inhibition of NF-κB and MAPK signaling cascades, reduction of inflammation mediators.
  • Cytoprotective action — protection of cells from chemical stress, maintenance of cellular homeostasis.
  • Antimicrobial activity — direct suppression of microorganism growth.

All mentioned mechanisms are confirmed by experimental data, are based on structural classes of phytoactive compounds, and are consistent with the results of objective biopharmacological studies.

Reference: MDPI+14PMC+14Википедия+14PMC


Synergy — Borassus flabellifer

Currently, no confirmed examples of physiological or pharmacological synergy between Borassus flabellifer and other plant or synthetic substances have been found in the available scientific data. Although there is information about its inclusion in combined preparations (e.g., anti-inflammatory soap with Borassus flabellifer extract and turmeric ijrpr.com, specific studies demonstrating additive, potentiating, or modulating interaction mechanisms with other taxa or compounds at the level of molecular target systems (receptors, enzymes, cascades) are absent.

Until data from in vitro, in vivo, or clinical studies are obtained, describing synergy is impossible. When such studies become available, a substantiated scientific description of interactions and possible synergistic mechanisms can be provided.


Geography of Use and Traditional Medicine — Borassus flabellifer

Borassus flabellifer is widely distributed in tropical and subtropical regions of South and Southeast Asia, including India, Sri Lanka, Bangladesh, Myanmar, Thailand, Cambodia, Laos, Vietnam, Malaysia, and Indonesia, and is also found in East Africa. In the traditional medicine of various ethnic groups, almost the entire plant is used: inflorescence sap, fruits, seeds, leaves, roots, and wood. In Indian and South Asian tradition, fresh inflorescence sap is consumed as a nutritious drink, and the thickened syrup is used as a tonic. In Ayurveda and Siddha medicine, a decoction of roots and flowers is used, and the fruit pulp is used for external applications. In Cambodia and Laos, a decoction of leaves and flowers is used for washing and compresses, and in Thai tradition, flower extracts are included in remedies for maintaining general body condition. In the historical chronicles of South India, the sugar palm is mentioned as a valuable medicinal and food plant as early as the 1st millennium AD, and archeo-ethnobotanical finds indicate its cultivation on the territory of ancient Dravidian states. Besides medical use, the palm had cultural and ritual significance: leaves were used for writing and making amulets, wood for ritual structures, and fruits and sap were part of festive dishes and ceremonial drinks. In some communities of Southeast Asia, the plant was considered a symbol of fertility and well-being, and its parts were used in purification and protection rituals. In African regions where the palm was introduced, it also gained importance in local practices, including the use of leaves in woven amulets and protective headgear.

Specifications
Made by Asiabiopharm Co Ltd
Country of origin Thailand
Reviews